Почетна › Dijabetes tipa 2 › Вирџинија
Kliničke studije za Dijabetes tipa 2 u državi Вирџинија
29 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Вирџинија.
Gradovi u državi Вирџинија
- Arlington19 студија
- Alexandria5 студија
- Charlottesville4 студија
- Norfolk4 студија
- Newport News4 студија
- Richmond4 студија
- Roanoke3 студија
Zvanični tekst studije (na engleskom)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- University of Virginia Health System, Charlottesville
Тражи се учесник
Узраст од 2 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07864168A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Tidewater Physicians Multispecialty Group, Newport News
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Seven Corners Medical Center, Falls Church
- Carient Heart and Vascular, Manassas
- York Clinical Research, Norfolk
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Manassas
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
- Centricity Research Suffolk Primary Care, Suffolk
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Virginia Nephrology Group, Arlington
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07843485A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- York Clinical Research, LLC, Norfolk
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Washington Center for Weight Management and Research, Arlington
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Carient Heart & Vascular - Manassas, Manassas
- Carient Heart and Vascular LLC-Reston, Reston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Newport News
- Research Site, Vienna
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Manassas
- Research Site, Norfolk
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Falls Church
- Research Site, Norfolk
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Burke Internal Medicine and Research, Burke
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 20. 10. 2026. · NCT07502508Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Manassas Clinical Research Center, Manassas
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 10. 2026. · NCT07527650A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- UVA Health Systems, Charlottesville
Тражи се учесникФаза 3
Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Suffolk, Suffolk
- Conquest Research, Vienna
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Manassas Clinical Research Center Inc, Burke
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Tidewater Physicians Multispecialty Group, Newport News
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Chippenham Johnston Willis Medical Center, Richmond
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Hampton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450Cooking Health-Oriented Meals to Prevent Dementia and Diabetes
- Virginia Tech, Blacksburg
Тражи се учесникЗдраве особе су добродошле
Узраст од 50 до 75 · Оба пола · Ажурирано 16. 9. 2026. · NCT07661368AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Carient Heart and Vascular, Manassas
- Dominion Medical Associates, Richmond
- VA Medical Center_Salem, Salem
- и још 1
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Riverside Family Medicine Residency Program, Newport News
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07521475HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Burke Internal Medicine & Research, Burke
- Tekton Research, Midlothian
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 23. 4. 2026. · NCT07546929Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
- University of Virginia Center for Diabetes Technology, Charlottesville
Тражи се учесник
Узраст од 30 до 80 · Оба пола · Ажурирано 9. 4. 2026. · NCT05766735Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- University of Virginia, Charlottesville
Тражи се учесникЗдраве особе су добродошле
Узраст од 30 до 55 · Оба пола · Ажурирано 23. 3. 2026. · NCT04791371Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Foot and Ankle Specialists of the Mid-Atlantic, Salem
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 10. 2. 2025. · NCT06681428Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.